Subclinical atherosclerosis in young β-thalassemia major patients

Hemoglobin

Volumn 33, Issue 6, 2009, Pages 463-474

  Tantawy, Azza A G ^a   Adly, Amira A M ^a   El Maaty, Mohamed G A ^b   Amin, Shatha A G ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Thalassemia major ( TM); Carotid artery intima media thickness (CIMT); Dyslipidemia; Subclinical atherosclerosis; Type 1 diabetes mellitus (type 1 DM)

Indexed keywords

APOLIPOPROTEIN A; CHOLESTEROL; FERRITIN; HEMOGLOBIN; HEMOGLOBIN F; HIGH DENSITY LIPOPROTEIN; LIPID; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BETA THALASSEMIA; BETA THALASSEMIA MAJOR; CARDIOVASCULAR RISK; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROPHORESIS; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL; ULTRASOUND;

ADOLESCENT; AGE FACTORS; ATHEROSCLEROSIS; BETA-THALASSEMIA; CASE-CONTROL STUDIES; CHILD; CHOLESTEROL; DIABETES MELLITUS, TYPE 1; DYSLIPIDEMIAS; FERRITINS; FETAL HEMOGLOBIN; HUMANS; LIPIDS; PROGNOSIS; RISK FACTORS; YOUNG ADULT;

EID: 72049123774     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630260903343616     Document Type: Article

References (36)

1. El-Hashemite N, Petrou M, Khalifa AS, Heshmat NM, Rady MS, Delhanty JD. Identification of novel Asian Indian and Japanese mutations causing b-thalassemia in the Egyptian population. Hum Genet. 1997;99(2):271-274.
2. Hussein G, Fawzy M, Serafi TE, et al. Rapid detection of b-thalassemia alleles in Egypt using naturally or amplified created restriction sites and direct sequencing: A step in disease control. Hemoglobin. 2007;31(1):49-62.
3. Aessopos A, Farmakis D, Tsironi M, et al. Endothelial function and arterial stiffness in sickle-thalassemia patients. Atherosclerosis. 2007;191(2):427-432.
4. Hahalis G, Kremastinos DT, Terzis G, et al. Global vasomotor dysfunction and accelerated vascular aging in b-thalassemia major. Atherosclerosis. 2008;198(2):448-457.
5. Kanter JE, Johansson F, LeBoeuf RC, Bornfeldt KE. Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques? Circ Res. 2007; 100(6):769-781.
6. Stakos DA, Schuster DP, Sparks EA, Wooley CF, Osei K, Boudoulas H. Cardiovascular effects of type 1 diabetes mellitus in children. Angiology. 2005;56(3):311-317.
7. Aggoun Y, Szezepanski I, Bonnet D. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events in children. Pediatr Res. 2005;58(2):173-178.
8. Järvisalo MJ, Raitakari M, Toikka JO, et al. Endothelial dysfunction and increased arterial intima-media thickness in children with type1 diabetes. Circulation. 2004;109(14):1750-1755.
9. Maioli M, Vigna GB, Tonolo G, et al. Plasma lipoprotein composition, apolipoprotein(a) concentration and isoforms in b-thalassemia. Atherosclerosis. 1997;131(1):127-133.
10. Dwivedi S, Kumar V. b-Thalassemia, hyperlipoproteinemia(a), and metabolic syndrome: Its low-cost holistic therapy. J Altern Complement Med. 2007;13(2):288-289.
11. Panayiotou A, Griffin M, Georgiou N, et al. ApoB/ApoA1 ratio and subclinical atherosclerosis. Int Angiol. 2008;27(1):74-80.
12. Chrysohoou C, Panagiotakos DB, Pitsavos C, et al. Distribution of serum lipids and lipoproteins in patients with b thalassaemia major; an epidemiological study in young adults from Greece. Lipids Health Dis. 2004;3(3):3-8.
13. WHO Study Group. Diabetes Mellitus. World Health Organization Technical Report Series: 727. Geneva: WHO, 1985.
14. Mosca A, Paleari R, Ivaldi G, Galanello R, Giordano PC. The role of Hemoglobin A (2) testing in the diagnosis of thalassemias and related hemoglobinopathies. J Cin Pathol. 2009;62(1):13-17.
15. Allain CC,Poom LS,Chan CSG, et al. Enzymatic determination of total serum cholesterol. Clin.Chem. 1974;20(4):470-475.
16. Wahlefeld AW. Triglycerids determination after enzymatic hydrolysis. In: Bergmeyer HU, Ed. Methods of Enzymatic Analysis, 2nd ed. New York: Academic Press. 1974;1831-1835.
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502.
18. Shamir R, Kassis H, Kaplan M, Naveh T, Shehadeh N. Glycemic control in adolescents with type 1 diabetes mellitus improves lipid serum levels and oxidative stress. Pediatr Diabetes. 2008;9(2):104-109.
19. Brizzi P, Isaja T, D'Agata A, Malaguarnera L, Malaguarnera M, Musumeci S. Oxidized LDL antibodies (OLAB) in patients with b-thalassemia major. J Atheroscler Thromb. 2002;9(3):139-144.
20. Brizzi P, Tonolo G, Bertrand G, et al. Autoantibodies against oxidized low-density lipoprotein (ox-LDL) and LDL oxidation status. Clin Chem Lab Med. 2004;42(2):164-170.
21. Amendola G, Danise P, Todisco N, D'Urzo G, Di Palma A, Di Concilio R. Lipid profile in b-thalassemia intermedia patients: Correlation with erythroid bone marrow activity. Int J Lab Hematol. 2007;29(3):172-176.
22. Livrea MA, Tesoriere L, Maggio A, D'Arpa D, Pintaudi AM, Pedone E. Oxidative modification of low-density lipoprotein and atherogenetic risk in b-thalassemia. Blood. 1998;92(10):3936-3942.
23. Ribault A, Durou MR, Letellier C, Wojcik F, Poirier JY, Ruelland A. Determination of lipoprotein(a) concentrations and apolipoprotein(a) molecular weights in diabetic patients. Diabetes Metab. 2000;26(2):107-112.
24. Imani SF, Hashemipour M, Kelishadi R. Lipid profile of children with type 1 diabetes compared to controls. ARYA J. (Adv Res Yields Across Atherosclerosis J.) 2006;2(1):36-38.
25. Feely J, Barry M, Keeling PW, Weir DG, Cooke T. Lipoprotein (a) in cirrhosis. BMJ. 1992; 304(6826):545-546.
26. Bustos P, Radojkovic C, Ulloa N, et al. Lipoprotein composition in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2005;18(3):257-264.
27. Maahs DM, Wadwa RP, McFann K, et al. Longitudinal lipid screening and use of lipid-lowering medications in pediatric type 1 diabetes. J Pediatr. 2007;150(2):146-150.
28. Labudovic DD, Toseska KN, Alabakovska SB, Todorova B. Apoprotein(a) phenotypes and plasma lipoprotein(a) concentration in patients with diabetes mellitus. Clin Biochem. 2003;36(7):545-551. (Pubitemid 37244017)
29. Cheung YF, Chow PC, Chan GC, Ha SY. Carotid intima-media thickness is increased and related to arterial stiffening in patients with b-thalassaemia major. Br J Haematol. 2006;135(5):732-734.
30. Reiter CD, Wang X, Tanus-Santos JE, et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med. 2002;8(12):1383-1389.
31. Fridlender ZG, Rund D. Myocardial infarction in a patient with b-thalassemia major: first report. Am J Hematol. 2004;75(1):52-55.
32. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109(23 Suppl 1):III27-32.
33. Singh TP, Groehn H, Kazmers A. Vascular function and carotid intimal-media thickness in children with insulin-dependent diabetes mellitus. J Am Coll Cardiol. 2003;41(4):661-665.
34. Moussa MA, Alsaeid M, Abdella N, Refai TM, Al-Sheikh N, Gomez JE. Lipoprotein (a) and other cardiovascular metabolic risk factors in Kuwaiti children with type-1 diabetes. Ann Nutr Metab. 2004;48(5):329-334.
35. Erciyas F, Taneli F, Arslan B, Uslu Y. Glycemic control, oxidative stress, and lipid profile in children with type 1 diabetes mellitus. Arch Med Res. 2004;35(2):134-140.
36. Orchard TJ, Costacou T, Kretowski A, Nesto RW. Type 1 diabetes and coronary artery disease. Diabetes Care. 2006;29(11):2528-2538.